Gkk. Hershey et al., THE ASSOCIATION OF ATOPY WITH A GAIN-OF-FUNCTION MUTATION IN THE ALPHA-SUBUNIT OF THE INTERLEUKIN-4 RECEPTOR, The New England journal of medicine, 337(24), 1997, pp. 1720-1725
Background Atopic diseases are very common, and atopy has a strong gen
etic predisposition. Methods Using single-strand conformation polymorp
hism analysis and DNA sequencing, we searched for mutations in the alp
ha subunit of the interleukin-4 receptor that would predispose persons
to atopy. We examined the prevalence of the alleles among patients wi
th allergic inflammatory disorders and among 50 prospectively recruite
d adults. Subjects with atopy were identified on the basis of an eleva
ted serum IgE level (greater than or equal to 95 IU per milliliter) or
a positive radioimmunosorbent test in response to standard inhalant a
llergens. The signaling function of mutant interleukin-4 receptor alph
a was examined by flow cytometry, binding assays, and immunoblotting.
Results A novel interleukin-4 receptor alpha allele was identified in
which guanine was substituted for adenine at nucleotide 1902, causing
a change from glutamine to arginine at position 576 (R576) in the cyto
plasmic domain of the interleukin-4 receptor alpha protein. The R576 a
llele was common among patients with allergic inflammatory disorders (
found in 3 of 3 patients with the hyper-IgE syndrome and 4 of 7 patien
ts with severe atopic dermatitis) and among the 50 prospectively recru
ited adults (found in 13 of 20 subjects with atopy and 5 of 30 without
atopy; P=0.001; relative risk of atopy among those with a mutant alle
le, 9.3). The R576 allele was associated with higher levels of express
ion of CD23 by interleukin-4 than the wild-type allele. This enhanced
signaling was associated with a change in the binding specificity of t
he adjacent tyrosine residue at position 575 to signal-transducing mol
ecules. Conclusions The R576 allele of interleukin-4 receptor alpha is
strongly associated with atopy. This mutation may predispose persons
to allergic diseases by altering the signaling function of the recepto
r. (C) 1997, Massachusetts Medical Society.